Conference Proceedings

Niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD): Correlative measures of tumor response in phase II GALAHAD study

Matthew Raymond Smith, Karim Fizazi, Shahneen Kaur Sandhu, William Kevin Kelly, Eleni Efstathiou, Primo Lara, Evan Y Yu, Daniel J George, Kim N Chi, Fred Saad, Jason Summa, Jamie M Freedman, Gary Mason, Byron M Espina, Eugene Zhu, Deborah S Ricci, Linda A Snyder, Jason S Simon, Shinta Cheng, Howard I Scher

JOURNAL OF CLINICAL ONCOLOGY | AMER SOC CLINICAL ONCOLOGY | Published : 2020

Grants

Funding Acknowledgements

Janssen Research & Development, LLC, USA